These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11578010)
21. D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Steen VD; Medsger TA; Rodnan GP Ann Intern Med; 1982 Nov; 97(5):652-9. PubMed ID: 7137731 [TBL] [Abstract][Full Text] [Related]
22. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. van den Hoogen FH; Boerbooms AM; Swaak AJ; Rasker JJ; van Lier HJ; van de Putte LB Br J Rheumatol; 1996 Apr; 35(4):364-72. PubMed ID: 8624641 [TBL] [Abstract][Full Text] [Related]
23. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine. Katayama Y; Kohriyama K; Matsui T J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917 [TBL] [Abstract][Full Text] [Related]
24. Dermal elastin and collagen in systemic sclerosis. Effect of D-penicillamine treatment. Pasquali Ronchetti I; Guerra D; Quaglino D; Vincenzi D; Manzini E; Canossi B; Manzini CU Clin Exp Rheumatol; 1989; 7(4):373-83. PubMed ID: 2591110 [TBL] [Abstract][Full Text] [Related]
25. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects. Shapiro LS; Prince RK; Buckingham RB; Rodnan GP J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687 [TBL] [Abstract][Full Text] [Related]
26. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment]. Jimenez SA; Sigal SH J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974 [TBL] [Abstract][Full Text] [Related]
27. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. Brewer EJ; Giannini EH; Kuzmina N; Alekseev L N Engl J Med; 1986 May; 314(20):1269-76. PubMed ID: 3517643 [TBL] [Abstract][Full Text] [Related]
28. Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. Furst DE; Clements PJ; Wong WK; Mayes MD; Wigley F; White B; Weisman M; Barr W; Moreland L; Martin R; Medsger TA; Steen V; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Peter JB; Seibold JR Rheumatology (Oxford); 2001 Jun; 40(6):615-22. PubMed ID: 11426017 [TBL] [Abstract][Full Text] [Related]
30. Postural changes, dysphagia, and systemic sclerosis. Barrera P; den Broeder AA; van den Hoogen FH; van Engelen BG; van de Putte LB Ann Rheum Dis; 1998 Jun; 57(6):331-8. PubMed ID: 9771206 [No Abstract] [Full Text] [Related]
31. Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial. Mayes MD; O'Donnell D; Rothfield NF; Csuka ME Arthritis Rheum; 2004 Feb; 50(2):553-7. PubMed ID: 14872498 [TBL] [Abstract][Full Text] [Related]
32. Connective tissue changes in systemic sclerosis and the use of D-penicillamine. Jayson MI Agents Actions Suppl; 1979; (5):149-57. PubMed ID: 294132 [No Abstract] [Full Text] [Related]
33. [A prospective study of plasma exchange in the treatment of diffuse scleroderma]. Ding C; Zhang X Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):616-9. PubMed ID: 8697930 [TBL] [Abstract][Full Text] [Related]
34. Combination therapies for systemic sclerosis. Denton CP; Black CM Springer Semin Immunopathol; 2001; 23(1-2):109-29. PubMed ID: 11455851 [No Abstract] [Full Text] [Related]
35. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis. Davis P; Bleehen SS Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821 [No Abstract] [Full Text] [Related]